{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:51:02Z","timestamp":1777618262249,"version":"3.51.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02274-6","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:06:34Z","timestamp":1768910794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Noradrenergic system involvement as a major driver of tension-type headache: a systematic review of the current evidence"],"prefix":"10.1186","volume":"27","author":[{"given":"Simone","family":"Braca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Cretella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Deligianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Kennelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilis-Spyridon","family":"Tseriotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna P.","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimos-Dimitrios","family":"Mitsikostas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"11","key":"2274_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBDH Collaborators","year":"2018","unstructured":"Collaborators GBDH (2018) Global, regional, and National burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 17(11):954\u2013976","journal-title":"Lancet Neurol"},{"issue":"3","key":"2274_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","volume":"27","author":"L Stovner","year":"2007","unstructured":"Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al (2007) The global burden of headache: a Documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193\u2013210","journal-title":"Cephalalgia"},{"issue":"11","key":"2274_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0895-4356(91)90147-2","volume":"44","author":"BK Rasmussen","year":"1991","unstructured":"Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population\u2013a prevalence study. J Clin Epidemiol 44(11):1147\u20131157","journal-title":"J Clin Epidemiol"},{"issue":"10053","key":"2274_CR4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"regional Global","year":"2016","unstructured":"Global regional (2016) National incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet 388(10053):1545\u20131602","journal-title":"Lancet"},{"issue":"6","key":"2274_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1046\/j.1468-2982.1999.019006602.x","volume":"19","author":"R Jensen","year":"1999","unstructured":"Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19(6):602\u2013621","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"2274_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1468-2982.2003.00574.x","volume":"23","author":"R Jensen","year":"2003","unstructured":"Jensen R (2003) Peripheral and central mechanisms in tension-type headache: an update. Cephalalgia 23(Suppl 1):49\u201352","journal-title":"Cephalalgia"},{"issue":"8","key":"2274_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1468-2982.2006.01150.x","volume":"26","author":"S Ashina","year":"2006","unstructured":"Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R (2006) Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 26(8):940\u2013948","journal-title":"Cephalalgia"},{"issue":"5","key":"2274_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1468-2982.2000.00070.x","volume":"20","author":"L Bendtsen","year":"2000","unstructured":"Bendtsen L (2000) Central sensitization in tension-type headache\u2013possible pathophysiological mechanisms. Cephalalgia 20(5):486\u2013508","journal-title":"Cephalalgia"},{"issue":"4","key":"2274_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/j.pain.0000000000001151","volume":"159","author":"WT Chen","year":"2018","unstructured":"Chen WT, Hsiao FJ, Ko YC, Liu HY, Wang PN, Fuh JL et al (2018) Comparison of somatosensory cortex excitability between migraine and strict-criteria tension-type headache: a Magnetoencephalographic study. Pain 159(4):793\u2013803","journal-title":"Pain"},{"issue":"1\u20132","key":"2274_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pain.2006.01.040","volume":"123","author":"L Buchgreitz","year":"2006","unstructured":"Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R (2006) Frequency of headache is related to sensitization: a population study. Pain 123(1\u20132):19\u201327","journal-title":"Pain"},{"issue":"7","key":"2274_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1468-2982.2006.01130.x","volume":"26","author":"G Sandrini","year":"2006","unstructured":"Sandrini G, Rossi P, Milanov I, Serrao M, Cecchini AP, Nappi G (2006) Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 26(7):782\u2013789","journal-title":"Cephalalgia"},{"issue":"6","key":"2274_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s12264-013-1468-6","volume":"30","author":"P Wang","year":"2014","unstructured":"Wang P, Du H, Chen N, Guo J, Gong Q, Zhang J et al (2014) Regional homogeneity abnormalities in patients with tension-type headache: a resting-state fMRI study. Neurosci Bull 30(6):949\u2013955","journal-title":"Neurosci Bull"},{"issue":"9","key":"2274_CR13","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1212\/01.wnl.0000183067.94400.80","volume":"65","author":"T Schmidt-Wilcke","year":"2005","unstructured":"Schmidt-Wilcke T, Leinisch E, Straube A, K\u00e4mpfe N, Draganski B, Diener HC et al (2005) Gray matter decrease in patients with chronic tension type headache. Neurology 65(9):1483\u20131486","journal-title":"Neurology"},{"issue":"1","key":"2274_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s10194-018-0834-6","volume":"19","author":"WT Chen","year":"2018","unstructured":"Chen WT, Chou KH, Lee PL, Hsiao FJ, Niddam DM, Lai KL et al (2018) Comparison of Gray matter volume between migraine and strict-criteria tension-type headache. J Headache Pain 19(1):4","journal-title":"J Headache Pain"},{"issue":"2","key":"2274_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1526-4610.2010.01768.x","volume":"51","author":"D Bezov","year":"2011","unstructured":"Bezov D, Ashina S, Jensen R, Bendtsen L (2011) Pain perception studies in tension-type headache. Headache 51(2):262\u2013271","journal-title":"Headache"},{"issue":"Pt 12","key":"2274_CR16","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/brain\/awn199","volume":"131","author":"L Buchgreitz","year":"2008","unstructured":"Buchgreitz L, Egsgaard LL, Jensen R, Arendt-Nielsen L, Bendtsen L (2008) Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study. Brain 131(Pt 12):3232\u20133238","journal-title":"Brain"},{"issue":"1\u20132","key":"2274_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0022-510X(02)00035-7","volume":"198","author":"P Sarchielli","year":"2002","unstructured":"Sarchielli P, Alberti A, Floridi A, Gallai V (2002) L-Arginine\/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content. J Neurol Sci 198(1\u20132):9\u201315","journal-title":"J Neurol Sci"},{"issue":"10","key":"2274_CR18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1526-4610.2004.04194.x","volume":"44","author":"JW Park","year":"2004","unstructured":"Park JW, Kim JS, Lee HK, Kim YI, Lee KS (2004) Serotonin transporter polymorphism and harm avoidance personality in chronic tension-type headache. Headache 44(10):1005\u20131009","journal-title":"Headache"},{"issue":"1\u20133","key":"2274_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejphar.2013.01.067","volume":"716","author":"A Pertovaara","year":"2013","unstructured":"Pertovaara A (2013) The noradrenergic pain regulation system: a potential target for pain therapy. Eur J Pharmacol 716(1\u20133):2\u20137","journal-title":"Eur J Pharmacol"},{"key":"2274_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-031-89525-8_2","volume":"1477","author":"G Fernandes","year":"2025","unstructured":"Fernandes G, Lam R, Park J, Drummond GT, Sur M (2025) Noradrenaline regulation of Brain-Body communication. Adv Exp Med Biol 1477:35\u201361","journal-title":"Adv Exp Med Biol"},{"key":"2274_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/B978-0-444-53491-0.00002-X","volume":"117","author":"DS Goldstein","year":"2013","unstructured":"Goldstein DS (2013) Differential responses of components of the autonomic nervous system. Handb Clin Neurol 117:13\u201322","journal-title":"Handb Clin Neurol"},{"key":"2274_CR22","doi-asserted-by":"publisher","first-page":"111270","DOI":"10.1016\/j.brainresbull.2025.111270","volume":"223","author":"DD Hu","year":"2025","unstructured":"Hu DD, Shi W, Jia X, Shao FM, Zhang L (2025) Alpha-2 receptor mediates the endogenous antagonistic regulation of itch and pain via descending noradrenaline pathway from the locus coeruleus. Brain Res Bull 223:111270","journal-title":"Brain Res Bull"},{"key":"2274_CR23","doi-asserted-by":"publisher","first-page":"638007","DOI":"10.3389\/fncir.2021.638007","volume":"15","author":"V Breton-Provencher","year":"2021","unstructured":"Breton-Provencher V, Drummond GT, Sur M (2021) Locus coeruleus norepinephrine in learned behavior: anatomical modularity and Spatiotemporal integration in targets. Front Neural Circuits 15:638007","journal-title":"Front Neural Circuits"},{"issue":"6","key":"2274_CR24","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/jnr.23956","volume":"95","author":"BK Taylor","year":"2017","unstructured":"Taylor BK, Westlund KN (2017) The noradrenergic locus coeruleus as a chronic pain generator. J Neurosci Res 95(6):1336\u20131346","journal-title":"J Neurosci Res"},{"issue":"11","key":"2274_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1468-1331.2010.03070.x","volume":"17","author":"L Bendtsen","year":"2010","unstructured":"Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J (2010) EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 17(11):1318\u20131325","journal-title":"Eur J Neurol"},{"issue":"9","key":"2274_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1526-4610.1994.hed3409531.x","volume":"34","author":"J Castillo","year":"1994","unstructured":"Castillo J, Mart\u00ednez F, Leira R, Lema M, Noya M (1994) Plasma monoamines in tension-type headache. Headache 34(9):531\u2013535","journal-title":"Headache"},{"issue":"1\u20132","key":"2274_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pain.2003.12.012","volume":"108","author":"S Ashina","year":"2004","unstructured":"Ashina S, Bendtsen L, Jensen R (2004) Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake Inhibition. Pain 108(1\u20132):108\u2013114","journal-title":"Pain"},{"key":"2274_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0447.1985.tb08070.x","volume":"320","author":"A Denaro","year":"1985","unstructured":"Denaro A, Martucci N, Ruggieri S, Manna V, Agnoli A (1985) Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists. Acta Psychiatr Scand Suppl 320:20\u201325","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2274_CR29","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906","journal-title":"Int J Surg"},{"issue":"4","key":"2274_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1600-0404.1992.tb05108.x","volume":"86","author":"V Gallai","year":"1992","unstructured":"Gallai V, Gaiti A, Sarchielli P, Coata G, Trequattrini A, Paciaroni M (1992) Evidence for an altered dopamine beta-hydroxylase activity in migraine and tension-type headache. Acta Neurol Scand 86(4):403\u2013406","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"2274_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10194-007-0384-9","volume":"8","author":"RB Leistad","year":"2007","unstructured":"Leistad RB, Stovner LJ, White LR, Nilsen KB, Westgaard RH, Sand T (2007) Noradrenaline and cortisol changes in response to low-grade cognitive stress differ in migraine and tension-type headache. J Headache Pain 8(3):157\u2013166","journal-title":"J Headache Pain"},{"issue":"1","key":"2274_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1526-4610.1994.hed3401035.x","volume":"34","author":"V Gallai","year":"1994","unstructured":"Gallai V, Sarchielli P, Trequattrini A, Paciaroni M, Usai F, Palumbo R (1994) Neuropeptide Y in juvenile migraine and tension-type headache. Headache 34(1):35\u201340","journal-title":"Headache"},{"issue":"11","key":"2274_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0333102413480755","volume":"33","author":"G D\u2019Andrea","year":"2013","unstructured":"D\u2019Andrea G, D\u2019Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG et al (2013) The role of tyrosine metabolism in the pathogenesis of chronic migraine. Cephalalgia 33(11):932\u2013937","journal-title":"Cephalalgia"},{"issue":"5","key":"2274_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0306-4530(89)90005-X","volume":"14","author":"E Martignoni","year":"1989","unstructured":"Martignoni E, Facchinetti F, Rossi F, Sances G, Genazzani AR, Nappi G (1989) Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine. Psychoneuroendocrinology 14(5):357\u2013363","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"2274_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1526-4610.1991.hed3109601.x","volume":"31","author":"T Shimomura","year":"1991","unstructured":"Shimomura T, Awaki E, Kowa H, Takahashi K (1991) Treatment of tension-type headache with Tizanidine hydrochloride: its efficacy and relationship to the plasma MHPG concentration. Headache 31(9):601\u2013604","journal-title":"Headache"},{"issue":"5","key":"2274_CR36","first-page":"397","volume":"90","author":"LB Jensen","year":"1982","unstructured":"Jensen LB, Jensen SB (1982) Effect of acupuncture on tension headache and urinary catecholamine excretion. Scand J Dent Res 90(5):397\u2013403","journal-title":"Scand J Dent Res"},{"issue":"3","key":"2274_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1468-2982.1993.1303197.x","volume":"13","author":"L Grazzi","year":"1993","unstructured":"Grazzi L, Bussone G (1993) Effect of biofeedback treatment on sympathetic function in common migraine and tension-type headache. Cephalalgia 13(3):197\u2013200","journal-title":"Cephalalgia"},{"issue":"5","key":"2274_CR38","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0924-980X(96)96532-7","volume":"101","author":"L Bendtsen","year":"1996","unstructured":"Bendtsen L, Jensen R, Olesen J (1996) Amitriptyline, a combined serotonin and noradrenaline re-uptake inhibitor, reduces exteroceptive suppression of Temporal muscle activity in patients with chronic tension-type headache. Electroencephalogr Clin Neurophysiol 101(5):418\u2013422","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"2","key":"2274_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0304-3959(94)90077-9","volume":"59","author":"H G\u00f6bel","year":"1994","unstructured":"G\u00f6bel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V et al (1994) Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 59(2):241\u2013249","journal-title":"Pain"},{"issue":"8","key":"2274_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1526-4610.1994.hed3408455.x","volume":"34","author":"K Nakashima","year":"1994","unstructured":"Nakashima K, Tumura R, Wang Y, Shimoda M, Sakuma K, Takahashi K (1994) Effects of Tizanidine administration on exteroceptive suppression of the temporalis muscle in patients with chronic tension-type headache. Headache 34(8):455\u2013457","journal-title":"Headache"},{"issue":"10","key":"2274_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1526-4610.1992.hed3210509.x","volume":"32","author":"R Fogelholm","year":"1992","unstructured":"Fogelholm R, Murros K (1992) Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 32(10):509\u2013513","journal-title":"Headache"},{"issue":"1\u20132","key":"2274_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autneu.2007.02.006","volume":"134","author":"Y Ozkul","year":"2007","unstructured":"Ozkul Y, Ay H (2007) Habituation of sympathetic skin response in migraine and tension type headache. Auton Neurosci 134(1\u20132):81\u201384","journal-title":"Auton Neurosci"},{"issue":"4","key":"2274_CR43","first-page":"108","volume":"107","author":"D Yerdelen","year":"2007","unstructured":"Yerdelen D, Acil T, Goksel B, Karata\u015f M (2007) Autonomic function in tension-type headache. Acta Neurol Belg 107(4):108\u2013111","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"2274_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1526-4610.1989.hed2903163.x","volume":"29","author":"PA Battistella","year":"1989","unstructured":"Battistella PA, Ruffilli R, Zacchello F (1989) Pupillary adrenergic sensitivity and idiopathic headache in pediatric patients. Headache 29(3):163\u2013166","journal-title":"Headache"},{"issue":"1","key":"2274_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1526-4610.2001.111006063.x","volume":"41","author":"V Di Piero","year":"2001","unstructured":"Di Piero V, Bruti G, Venturi P, Talamonti F, Biondi M, Di Legge S et al (2001) Aminergic tone correlates of migraine and tension-type headache: a study using the tridimensional personality questionnaire. Headache 41(1):63\u201371","journal-title":"Headache"},{"issue":"3","key":"2274_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1526-4610.1971.hed1103110.x","volume":"11","author":"S Diamond","year":"1971","unstructured":"Diamond S, Baltes BJ (1971) Chronic tension headache\u2013treated with amitriptyline\u2013a double-blind study. Headache 11(3):110\u2013116","journal-title":"Headache"},{"issue":"11","key":"2274_CR47","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1212\/WNL.38.11.1720","volume":"38","author":"A Indaco","year":"1988","unstructured":"Indaco A, Carrieri PB (1988) Amitriptyline in the treatment of headache in patients with parkinson\u2019s disease: a double-blind placebo-controlled study. Neurology 38(11):1720\u20131722","journal-title":"Neurology"},{"issue":"6","key":"2274_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1526-4610.1998.3806453.x","volume":"38","author":"R Cerbo","year":"1998","unstructured":"Cerbo R, Barbanti P, Fabbrini G, Pascali MP, Catarci T (1998) Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache 38(6):453\u2013457","journal-title":"Headache"},{"issue":"5","key":"2274_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1046\/j.1468-2982.1999.019005531.x","volume":"19","author":"A Oguzhanoglu","year":"1999","unstructured":"Oguzhanoglu A, Sahiner T, Kurt T, Akalin O (1999) Use of amitriptyline and Fluoxetine in prophylaxis of migraine and tension-type headaches. Cephalalgia 19(5):531\u2013532","journal-title":"Cephalalgia"},{"issue":"17","key":"2274_CR50","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1001\/jama.285.17.2208","volume":"285","author":"KA Holroyd","year":"2001","unstructured":"Holroyd KA, O\u2019Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 285(17):2208\u20132215","journal-title":"JAMA"},{"issue":"4","key":"2274_CR51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000080960","volume":"50","author":"L Rampello","year":"2004","unstructured":"Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I et al (2004) Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 50(4):322\u2013328","journal-title":"Neuropsychobiology"},{"issue":"3","key":"2274_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jnnp.61.3.285","volume":"61","author":"L Bendtsen","year":"1996","unstructured":"Bendtsen L, Jensen R, Olesen J (1996) A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 61(3):285\u2013290","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2274_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10194-003-0034-9","volume":"4","author":"C Boz","year":"2003","unstructured":"Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M (2003) Sertraline versus amitriptyline inthe prophylactic therapy of non-depressed chronic tension-typeheadache patients. J Headache Pain 4(2):72\u201378","journal-title":"J Headache Pain"},{"issue":"7","key":"2274_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1526-4610.1990.hed3007439.x","volume":"30","author":"G Nappi","year":"1990","unstructured":"Nappi G, Sandrini G, Granella F, Ruiz L, Cerutti G, Facchinetti F et al (1990) A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. Headache 30(7):439\u2013444","journal-title":"Headache"},{"issue":"4","key":"2274_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1600-0404.1997.tb00277.x","volume":"96","author":"DD Mitsikostas","year":"1997","unstructured":"Mitsikostas DD, Gatzonis S, Thomas A, Ilias A (1997) Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 96(4):247\u2013251","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"2274_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","volume":"42","author":"JR Saper","year":"2002","unstructured":"Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR (2002) Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 42(6):470\u2013482","journal-title":"Headache"},{"issue":"1","key":"2274_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10194-005-0251-5","volume":"7","author":"D Bettucci","year":"2006","unstructured":"Bettucci D, Testa L, Calzoni S, Mantegazza P, Viana M, Monaco F (2006) Combination of Tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. J Headache Pain 7(1):34\u201336","journal-title":"J Headache Pain"},{"issue":"8","key":"2274_CR58","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1526-4610.2000.040008633.x","volume":"40","author":"K Murros","year":"2000","unstructured":"Murros K, Kataja M, Hedman C, Havanka H, S\u00e4k\u00f6 E, F\u00e4rkkil\u00e4 M et al (2000) Modified-release formulation of Tizanidine in chronic tension-type headache. Headache 40(8):633\u2013637","journal-title":"Headache"},{"issue":"2","key":"2274_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1468-1331.2006.01607.x","volume":"14","author":"L Bendtsen","year":"2007","unstructured":"Bendtsen L, Buchgreitz L, Ashina S, Jensen R (2007) Combination of low-dose Mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. Eur J Neurol 14(2):187\u2013193","journal-title":"Eur J Neurol"},{"issue":"10","key":"2274_CR60","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1212\/01.WNL.0000127282.90920.8C","volume":"62","author":"L Bendtsen","year":"2004","unstructured":"Bendtsen L, Jensen R (2004) Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 62(10):1706\u20131711","journal-title":"Neurology"},{"issue":"2","key":"2274_CR61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.33588\/rn.3702.2002498","volume":"37","author":"A Mart\u00edn-Araguz","year":"2003","unstructured":"Mart\u00edn-Araguz A, Bustamante-Mart\u00ednez C, de Pedro-Pijo\u00e1n JM (2003) [Treatment of chronic tension type headache with Mirtazapine and amitriptyline]. Rev Neurol 37(2):101\u2013105","journal-title":"Rev Neurol"},{"issue":"7","key":"2274_CR62","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1526-4610.2000.00089.x","volume":"40","author":"LC Adelman","year":"2000","unstructured":"Adelman LC, Adelman JU, Von Seggern R, Mannix LK (2000) Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. Headache 40(7):572\u2013580","journal-title":"Headache"},{"issue":"4","key":"2274_CR63","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1468-2982.2007.01300.x","volume":"27","author":"NP Zissis","year":"2007","unstructured":"Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G et al (2007) A randomized, double-blind, placebo-controlled study of Venlafaxine XR in out-patients with tension-type headache. Cephalalgia 27(4):315\u2013324","journal-title":"Cephalalgia"},{"issue":"3","key":"2274_CR64","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1526-4610.1990.hed3003118.x","volume":"30","author":"M Langemark","year":"1990","unstructured":"Langemark M, Loldrup D, Bech P, Olesen J (1990) Clomipramine and Mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 30(3):118\u2013121","journal-title":"Headache"},{"issue":"1","key":"2274_CR65","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1526-4610.1994.hed3401044.x","volume":"34","author":"V Manna","year":"1994","unstructured":"Manna V, Bolino F, Di Cicco L (1994) Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 34(1):44\u201349","journal-title":"Headache"},{"issue":"5","key":"2274_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1526-4610.1985.hed2505273.x","volume":"25","author":"R Fogelholm","year":"1985","unstructured":"Fogelholm R, Murros K (1985) Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 25(5):273\u2013275","journal-title":"Headache"},{"issue":"7","key":"2274_CR67","first-page":"923","volume":"16","author":"SA Mousavi","year":"2011","unstructured":"Mousavi SA, Mirbod SM, Khorvash F (2011) Comparison between efficacy of Imipramine and transcutaneous electrical nerve stimulation in the prophylaxis of chronic tension-type headache: a randomized controlled clinical trial. J Res Med Sci 16(7):923\u2013927","journal-title":"J Res Med Sci"},{"issue":"7","key":"2274_CR68","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1526-4610.1998.3807523.x","volume":"38","author":"Z Walker","year":"1998","unstructured":"Walker Z, Walker RW, Robertson MM, Stansfeld S (1998) Antidepressant treatment of chronic tension-type headache: a comparison between Fluoxetine and Desipramine. Headache 38(7):523\u2013528","journal-title":"Headache"},{"issue":"9","key":"2274_CR69","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1046\/j.1526-4610.2003.03193.x","volume":"43","author":"KA Holroyd","year":"2003","unstructured":"Holroyd KA, Labus JS, O\u2019Donnell FJ, Cordingley GE (2003) Treating chronic tension-type headache not responding to amitriptyline hydrochloride with Paroxetine hydrochloride: a pilot evaluation. Headache 43(9):999\u20131004","journal-title":"Headache"},{"issue":"2","key":"2274_CR70","doi-asserted-by":"publisher","first-page":"113674","DOI":"10.1016\/j.celrep.2024.113674","volume":"43","author":"R Kumari","year":"2024","unstructured":"Kumari R, Pascalau R, Wang H, Bajpayi S, Yurgel M, Quansah K et al (2024) Sympathetic NPY controls glucose homeostasis, cold tolerance, and cardiovascular functions in mice. Cell Rep 43(2):113674","journal-title":"Cell Rep"},{"issue":"2","key":"2274_CR71","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0006-8993(81)90792-7","volume":"221","author":"DJ Pettibone","year":"1981","unstructured":"Pettibone DJ, Mueller GP (1981) Clonidine releases immunoreactive beta-endorphin from rat Para distalis. Brain Res 221(2):409\u2013414","journal-title":"Brain Res"},{"issue":"3","key":"2274_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1468-2982.1994.014003219.x","volume":"14","author":"R Jensen","year":"1994","unstructured":"Jensen R, Hindberg I (1994) Plasma serotonin increase during episodes of tension-type headache. Cephalalgia 14(3):219\u2013222 discussion 181","journal-title":"Cephalalgia"},{"issue":"5","key":"2274_CR73","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1046\/j.1468-2982.1993.1305346.x","volume":"13","author":"R Leira","year":"1993","unstructured":"Leira R, Castillo J, Martinez F, Prieto JM, Noya M (1993) Platelet-rich plasma serotonin levels in tension-type headache and depression. Cephalalgia 13(5):346\u2013348","journal-title":"Cephalalgia"},{"issue":"1","key":"2274_CR74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-021-00257-2","volume":"7","author":"S Ashina","year":"2021","unstructured":"Ashina S, Mitsikostas DD, Lee MJ, Yamani N, Wang SJ, Messina R et al (2021) Tension-type headache. Nat Rev Dis Primers 7(1):24","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2274_CR75","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1468-2982.2008.01739.x","volume":"29","author":"M Lindholt","year":"2009","unstructured":"Lindholt M, Petersen KA, Tvedskov JF, Iversen HK, Olesen J, Tfelt-Hansen P (2009) Lack of effect of norepinephrine on cranial haemodynamics and headache in healthy volunteers. Cephalalgia 29(3):384\u2013387","journal-title":"Cephalalgia"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02274-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02274-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:03:24Z","timestamp":1770987804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02274-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02274-6","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.B has received personal compensation from Eli Lilly for oral communications. C.D. has received travel grants and honoraria from AstraZeneca, Merck & Co, Pfizer and Teva Pharmaceuticals and research grants from the International Headache Society and the Hellenic Neurology Society. V.S.T has received travel grants from ECTRIMS and the European Academy of Neurology, as well as coverage of congress registration fees from Inovis, Genesis Pharma and Novartis. A.P.A reports advisory board at Neuresta, Zenith Scientific, Modulight. Speaker\/Speaker board at AbbVie, Pfizer, Organon, TEVA. Consultant at Neuresta, Zenith Scientific, General Services Consulting. Grant support for research or education at AbbVie, Pfizer, Ipsen, Medical Research Foundation, Brain Research UK, Migraine Trust, Medical Research Council, National Institute of Health. D.D.M has received fees and travel grants from AbbVie\/Allergan, Amgen, Eli Lilly and Company, ELPEN, Genesis Pharma, Lundberg, Merck & Co, Mylan, Novartis, Roche, Sanofi, Pfizer, and Teva Pharmaceuticals. He has also participated in clinical trials for Amgen, Eli Lily and Company, Lundberg, Novartis, Pfizer, and Teva Pharmaceuticals as the principal investigator. D.D.M is also the president of the Hellenic Headache Society and is a member of the Management Group of the Headache Scientific Panel of the European Academy of Neurology. He also served in the past as President of the European Headache Federation. D.D.M has also had commercial assistance and\/or received honoraria from AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, Genesis Pharma, Helion, Lundbeck, Merck and Co, Novartis, Orion Pharma, Pfizer, Roche and Teva Pharmaceuticals. T.M Received travel grant from AbbVie. L.K and G.C report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}